Navigation Links
India to Spend Rs.10 bn on Polio Eradication Strategies

India Thursday approved Rs.10.39 billion for implementing polio eradication strategies during 2006-07 besides Rs.200 million for corrective surgery and rehabilitation of polio victims. //

"The Cabinet Committee on Economic Affairs (CCEA) has approved funds of Rs.10.39 billion for implementing polio eradication strategies in the year 2006-07," Information and Broadcasting Minister P.R. Dasmunsi told the media after the cabinet meeting chaired by Prime Minister Manmohan Singh.

The strategies envisage holding national immunisation days throughout the country and sub-national immunisation days in high-risk states and districts.

The immunisation programme is monitored by the Indian Expert Advisory Group (IEAG). India has made considerable progress in checking the spread of polio with around 30 cases being reported in 2005-06.

"The CCEA has also given approval for corrective surgery and rehabilitation of the polio victims and to equip them to earn their livelihood and lead a dignified life in the community," the minister said.

For this, Rs.200 million has been earmarked.

As per data compiled by the National Polio Surveillance Project, being conducted jointly with the WHO, there are about 20,000 polio-afflicted children in the country.

Each child will get an average of Rs.10,000 for corrective surgery, fitting of prostheses, calipers/boots of good and light quality, besides residency and training of victim and attendant during treatment and physiotherapy.

(Source: IANS News)
'"/>




Page: 1

Related medicine news :

1. Is Diabetes the Leading Cause of Kidney Failure in India
2. AIDS Disaster in India is Imminent
3. Indian Prime Minister has successful Knee Replacement Surgery
4. International community warns India on HIV situation
5. India takes on foot-and-mouth disease by vaccinating animals
6. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
7. India to benefit from pharma companies move
8. Healthcare sector is now a multi billion-dollar industry in India
9. The World Bank funds private Hospital in India
10. Parke-Davis (India) runs into rough weather – Court orders attachment of asset
11. Indian Doctor granted US patent on organ regeneration
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The Visiting ... Day Market. Featuring a collection of specialty vendors and unique items from across the ... and quality-focused health and wellness services offered by the VNA. The boutique will ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... LA (PRWEB) , ... October 12, 2017 , ... Planet ... in the U.S., announced today its plans to open a flagship location in Covington, ... occupy the former Rooms To Go store next to Office Depot in the Holiday ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... been named one of Michigan’s 2017 Best and Brightest in Wellness® by Best ... in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to 2 ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Labs announces the European launch of their new low volume, high ... in Cambridge, U.K on October 4th. The ... with unprecedented speed and sensitivity while using far less sample volume ... ... ...
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: